News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Warns Naproxen Users; Bayer Healthcare's Aleve Latest Drug To Draw Scrutiny



10/19/2005 5:12:30 PM

The head of the U.S. drug safety agency on Tuesday said the United States was keeping "all regulatory options open" as it studied data showing increased heart risks from some painkillers. U.S. health regulators on Monday warned of heart risks connected to the over-the-counter painkiller naproxen, which is sold as a generic and under several brand names, including Bayer AG's Aleve, and as Roche AG subsidiary Roche Palo Alto's Naprosyn. The warning follows studies showing increased heart risks in two prescription painkillers -- Merck & Co. Inc.'s Vioxx, which the company has withdrawn, and Pfizer Inc's Celebrex, which is still on the market.

Read at Chicago Tribune
Read at CNN
Read at Forbes
Read at Reuters
Read at AP
Read at HealthDay
Read at WebMD
Read at WebMD


comments powered by Disqus
Chicago Tribune
CNN
Forbes
Reuters
AP
HealthDay
WebMD
WebMD
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES